Skip to main content
. 2022 Jan 17;11(2):452. doi: 10.3390/jcm11020452

Table 2.

Pathologies of the study groups.

Characteristics Preeclampsia
(n = 42)
Control
(n = 44)
p-Value
Respiratory distress syndrome, n (%) 0.482
No 10 (23.81) 12 (27.27)
Mild 11 (26.19) 12 (27.27)
Moderate 11 (26.19) 15 (34.09)
Severe 10 (23.81) 5 (11.36)
Surfactant, n (%) 16 (38.1) 5 (11.36) 0.004
CPAP, n (%) 0.041
No 14 (33.33) 13 (29.55)
24 6 (14.29) 9 (20.45)
36 1 (2.38) 0 (0)
48 10 (23.81) 2 (4.55)
72 2 (4.76) 9 (20.45)
>72 9 (21.43) 11 (25)
SIMV, n (%) 0.009
No 27 (64.29) 39 (88.64)
24 3 (7.14) 1 (2.27)
36 0 (0) 1 (2.27)
48 6 (14.29) 0 (0)
>72 6 (14.29) 3 (6.82)
IVH, nr (%) 0.085
Gr. I 16 (38.1) 7 (15.91)
Gr. II 2 (4.76) 2 (4.55)
Gr. III 1 (2.38) 1 (2.27)
No 23 (54.76) 34 (77.27)
Hypoglycemia (< 40 mg/dL), n (%) 16 (38.1) 10 (22.73) 0.121
pH < 7, n (%) 2 (4.76) 1 (2.27) 0.612
HCO3 < 15 mEq/L, n (%) 5 (11.9) 1 (2.27) 0.106
BE < −4 mmol/L, n (%) 19 (45.24) 23 (52.27) 0.514
Thrombocytopenia, n (%) 6 (14.29) 2 (4.55) 0.152
Neutropenia, n (%) 14 (33.33) 7 (15.91) 0.06

CPAP = continuous positive airway pressure, SIMV = synchronized intermittent mandatory ventilation, IVH = intraventricular hemorrhage, HCO3 = bicarbonate, BE = basal excess, n = number.